RBC Capital Initiates Coverage on Drug Manufacturer Stocks AGN & ENDP
Tweet Send to a FriendGet Alerts AGN Hot Sheet
Price: $98.15 -0.36%
Rating Summary:
16 Buy, 5 Hold, 1 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 10 | Down: 23 | New: 22
Rating Summary:
16 Buy, 5 Hold, 1 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 10 | Down: 23 | New: 22
Trade AGN Now!
RBC Capital initiates coverage on Allergan (NYSE: AGN) with an Outperform rating. PT $77.
RBC initiates coverage on Endo Pharmaceuticals (Nasdaq: ENDP) with a Sector Perform rating. PT $30.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
RBC initiates coverage on Endo Pharmaceuticals (Nasdaq: ENDP) with a Sector Perform rating. PT $30.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- UPDATE: Michael Kors (KORS) Under-Appreciated; Canaccord Genuity Starts at Buy
- Northland Securities Starts World Energy Solutions (XWES) at Outperform
- ISI Group Starts PAREXEL International (PRXL) at Neutral
Create E-mail Alert Related Categories
New CoverageRelated Entities
RBC Capital
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
